Grace Gallagher
YOU?
Author Swipe
View article: Clinician- and Facility-Level Factors Associated With Receipt of Nonguideline Chemotherapy Regimens in Women With Stage I-IIIA Breast Cancer
Clinician- and Facility-Level Factors Associated With Receipt of Nonguideline Chemotherapy Regimens in Women With Stage I-IIIA Breast Cancer Open
PURPOSE We examined clinician- and facility-level factors associated with selection of nonguideline chemotherapy at treatment initiation in women with stage I-IIIA breast cancer (BC). METHODS The Optimal Breast Cancer Chemotherapy Dosing S…
View article: Evaluating post-T-DXd treatment strategies in HER2-positive metastatic breast cancer
Evaluating post-T-DXd treatment strategies in HER2-positive metastatic breast cancer Open
Our study indicates that patients emerge from T-DXd treatment with highly refractory disease. These findings highlight the urgent need for optimized treatment strategies and novel therapeutic options for this patient population.
View article: Provider billing margin and cancer treatment selection: population based cohort study
Provider billing margin and cancer treatment selection: population based cohort study Open
Objective To estimate the association between the billing (profit) margin and clinical benefit of cancer treatments and use by oncologists. Design Retrospective population based cohort study Setting Population based sample using fee-for-se…
View article: Trends in enforcement of National Comprehensive Cancer Network financial conflict of interest policy
Trends in enforcement of National Comprehensive Cancer Network financial conflict of interest policy Open
Background The National Comprehensive Cancer Network (NCCN) financial conflict of interest (FCOI) policy sets dollar maximums for panelists, but violations may occur. Methods We studied NCCN Guidelines panelists for the 20 most prevalent c…
View article: Data from Patient Characteristics Associated with Intended Nonguideline Chemotherapy in Women with Stage I to IIIA Breast Cancer
Data from Patient Characteristics Associated with Intended Nonguideline Chemotherapy in Women with Stage I to IIIA Breast Cancer Open
Background:Guidelines informing chemotherapy regimen selection are based on clinical trials with participants who do not necessarily represent general populations with breast cancer. Understanding who receives nonguideline regimens is impo…
View article: Supplementary Table 1 from Patient Characteristics Associated with Intended Nonguideline Chemotherapy in Women with Stage I to IIIA Breast Cancer
Supplementary Table 1 from Patient Characteristics Associated with Intended Nonguideline Chemotherapy in Women with Stage I to IIIA Breast Cancer Open
Supplementary Table 1. Association between patient factors and guideline chemotherapy administered outside of period in which regimens were included in the guidelines
View article: Patient characteristics associated with delayed time to adjuvant chemotherapy among women treated for stage I–<scp>IIIA</scp> breast cancer
Patient characteristics associated with delayed time to adjuvant chemotherapy among women treated for stage I–<span>IIIA</span> breast cancer Open
For patients with breast cancer, delays in chemotherapy initiation have been adversely associated with recurrence and survival. We evaluated patient‐level factors associated with delayed chemotherapy initiation, from both diagnosis and sur…
View article: Trends in chemotherapy use for early-stage breast cancer from 2006 to 2019
Trends in chemotherapy use for early-stage breast cancer from 2006 to 2019 Open
Background Little is known about how use of chemotherapy has evolved in breast cancer patients. We therefore describe chemotherapy patterns for women with stage I-IIIA breast cancer in the Optimal Breast Cancer Chemotherapy Dosing (OBCD) S…
View article: Supplementary Figure S1 from Hypertension and Risk of Endometrial Cancer: A Pooled Analysis in the Epidemiology of Endometrial Cancer Consortium (E2C2)
Supplementary Figure S1 from Hypertension and Risk of Endometrial Cancer: A Pooled Analysis in the Epidemiology of Endometrial Cancer Consortium (E2C2) Open
Figure S1 shows the study flowchart for the inclusion of participants. It depicts how we arrived at our final analytic population.
View article: Data from Hypertension and Risk of Endometrial Cancer: A Pooled Analysis in the Epidemiology of Endometrial Cancer Consortium (E2C2)
Data from Hypertension and Risk of Endometrial Cancer: A Pooled Analysis in the Epidemiology of Endometrial Cancer Consortium (E2C2) Open
Background:The incidence rates of endometrial cancer are increasing, which may partly be explained by the rising prevalence of obesity, an established risk factor for endometrial cancer. Hypertension, another component of metabolic syndrom…
View article: Supplementary Figure S1 from Hypertension and Risk of Endometrial Cancer: A Pooled Analysis in the Epidemiology of Endometrial Cancer Consortium (E2C2)
Supplementary Figure S1 from Hypertension and Risk of Endometrial Cancer: A Pooled Analysis in the Epidemiology of Endometrial Cancer Consortium (E2C2) Open
Figure S1 shows the study flowchart for the inclusion of participants. It depicts how we arrived at our final analytic population.
View article: Supplementary Table S1 from Hypertension and Risk of Endometrial Cancer: A Pooled Analysis in the Epidemiology of Endometrial Cancer Consortium (E2C2)
Supplementary Table S1 from Hypertension and Risk of Endometrial Cancer: A Pooled Analysis in the Epidemiology of Endometrial Cancer Consortium (E2C2) Open
Characteristics of the 27 studies included in the E2C2 pooled analysis
View article: Data from Hypertension and Risk of Endometrial Cancer: A Pooled Analysis in the Epidemiology of Endometrial Cancer Consortium (E2C2)
Data from Hypertension and Risk of Endometrial Cancer: A Pooled Analysis in the Epidemiology of Endometrial Cancer Consortium (E2C2) Open
Background:The incidence rates of endometrial cancer are increasing, which may partly be explained by the rising prevalence of obesity, an established risk factor for endometrial cancer. Hypertension, another component of metabolic syndrom…
View article: Supplementary Table S2 from Hypertension and Risk of Endometrial Cancer: A Pooled Analysis in the Epidemiology of Endometrial Cancer Consortium (E2C2)
Supplementary Table S2 from Hypertension and Risk of Endometrial Cancer: A Pooled Analysis in the Epidemiology of Endometrial Cancer Consortium (E2C2) Open
Association of Hypertension Status with Endometrial Cancer by Histologic Subtype
View article: Supplementary Table S1 from Hypertension and Risk of Endometrial Cancer: A Pooled Analysis in the Epidemiology of Endometrial Cancer Consortium (E2C2)
Supplementary Table S1 from Hypertension and Risk of Endometrial Cancer: A Pooled Analysis in the Epidemiology of Endometrial Cancer Consortium (E2C2) Open
Characteristics of the 27 studies included in the E2C2 pooled analysis
View article: Supplementary Figure S2 from Hypertension and Risk of Endometrial Cancer: A Pooled Analysis in the Epidemiology of Endometrial Cancer Consortium (E2C2)
Supplementary Figure S2 from Hypertension and Risk of Endometrial Cancer: A Pooled Analysis in the Epidemiology of Endometrial Cancer Consortium (E2C2) Open
Figure S2 is a forest plot of the association between hypertension and endometrial cancer by study site. It displays the associations between hypertension and endometrial cancer for each study site included grouped by study type (case-cont…
View article: Supplementary Table S2 from Hypertension and Risk of Endometrial Cancer: A Pooled Analysis in the Epidemiology of Endometrial Cancer Consortium (E2C2)
Supplementary Table S2 from Hypertension and Risk of Endometrial Cancer: A Pooled Analysis in the Epidemiology of Endometrial Cancer Consortium (E2C2) Open
Association of Hypertension Status with Endometrial Cancer by Histologic Subtype
View article: Supplementary Figure S2 from Hypertension and Risk of Endometrial Cancer: A Pooled Analysis in the Epidemiology of Endometrial Cancer Consortium (E2C2)
Supplementary Figure S2 from Hypertension and Risk of Endometrial Cancer: A Pooled Analysis in the Epidemiology of Endometrial Cancer Consortium (E2C2) Open
Figure S2 is a forest plot of the association between hypertension and endometrial cancer by study site. It displays the associations between hypertension and endometrial cancer for each study site included grouped by study type (case-cont…
View article: Industry Payments to Physicians Endorsing Drugs and Devices on a Social Media Platform
Industry Payments to Physicians Endorsing Drugs and Devices on a Social Media Platform Open
This study evaluates adherence to industry and professional standards among physicians endorsing drugs and devices on a social media platform.
View article: Trends in financial payments from industry to US cancer centers, 2014-2021
Trends in financial payments from industry to US cancer centers, 2014-2021 Open
Background Industry payments to US cancer centers are poorly understood. Methods US National Cancer Institute (NCI)–designated comprehensive cancer centers were identified (n = 51). Industry payments to NCI–designated comprehensive cancer …
View article: Hypertension and Risk of Endometrial Cancer: A Pooled Analysis in the Epidemiology of Endometrial Cancer Consortium (E2C2)
Hypertension and Risk of Endometrial Cancer: A Pooled Analysis in the Epidemiology of Endometrial Cancer Consortium (E2C2) Open
Background: The incidence rates of endometrial cancer are increasing, which may partly be explained by the rising prevalence of obesity, an established risk factor for endometrial cancer. Hypertension, another component of metabolic syndro…
View article: Skeletal muscle adiposity and outcomes in candidates for lung transplantation: a lung transplant body composition cohort study
Skeletal muscle adiposity and outcomes in candidates for lung transplantation: a lung transplant body composition cohort study Open
CT measurement of body composition may improve lung transplant candidate selection. We assessed whether skeletal muscle adipose deposition on abdominal and thigh CT scans was associated with 6 min walk distance (6MWD) and wait-list surviva…